查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1862684

機器人輸尿管鏡市場按產品類型（可重複使用與一次性使用）、技術、最終用戶和應用分類－2025年至2032年全球預測

Robotic Ureteroscopy Market by Product Type, Reusable Vs Disposable, Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，機器人輸尿管鏡市場規模將達到 20.5905 億美元，複合年成長率為 16.69%。

關鍵市場統計數據
基準年 2024 5.9893億美元
預計年份：2025年 6.972億美元
預測年份 2032 2,059,050,000 美元
複合年成長率 (%) 16.69%

全面概述機器人輸尿管鏡技術、臨床促進因素和影響其近期應用的營運考量

機器人輸尿管鏡手術結合了精密器械、先進的光學技術和不斷發展的機器人驅動技術，正在重新定義內視鏡泌尿系統，從而提高手術效率和臨床療效。隨著臨床醫生尋求能夠減輕疲勞、提高在複雜解剖結構中操作靈活性以及實現雷射碎石和治療性介入精準控制的解決方案，機器人系統正逐漸成為傳統內視鏡手術的重要輔助手段。除了臨床表現之外，諸如消毒物流、一次性器械使用流程以及影響醫院吞吐量和單次手術成本的籌資策略等營運因素，也日益影響技術發展趨勢。

本節透過描述定義目前應用模式的核心技術類別、設備配置和臨床應用案例，為我們的分析奠定了基礎。我們重點闡述了軟性內視鏡和半剛性內視鏡之間的相互作用，以及為降低交叉感染風險而日益成長的對一次性使用和可重複使用方案的需求，並探討了不同消毒途徑對醫院營運的影響。此外，我們還介紹了主動式和半主動式機器人手術模式之間的區別，這種區別決定了系統的複雜性、控制精度以及與現有泌尿系統手術室的整合程度。

本導言面向手術室、門診手術中心和研究機構的相關人員，探討了關鍵的臨床和商業性問題：針對診斷性切片檢查、取石和治療性消融等特定臨床應用，最佳技術路徑是什麼？監理和採購環境如何影響科技的應用？醫療設備製造商、服務供應商和臨床領導者在哪些方面能夠創造關鍵價值？

技術、臨床和商業性轉折點的策略整合正在重塑機器人輸尿管鏡手術格局。

機器人輸尿管鏡手術領域正經歷技術、臨床和商業性層面的多重變革。在技​​術方面，手術操作正從純粹的手動內視鏡操作轉向採用動力或氣動驅動、配備精密觸覺介面和半自動功能的系統，從而加速提升手術精度並降低操作者差異。同時，光學、雷射傳輸和能量調製技術的進步也進一步拓展了結石清除和腫瘤消融的治療範圍。

臨床上，醫療服務正朝著微創工作流程轉變，優先考慮診療量、感染控制和一致的治療效果。一次性醫療器材在需要減少交叉感染和高效週轉的環境中越來越普遍，而可重複使用的平台則圍繞著完善的消毒通訊協定和生命週期管理不斷發展。在商業性，成熟的醫療器材原始設備製造商 (OEM)、專業的機器人公司以及能夠規模化生產一次性醫療器材和複雜機電組件的契約製造合作夥伴正在形成差異化格局。這種轉變正在推動新的合作模式、策略夥伴關係以及對臨床證據產生的定向投資。

法規結構和支付方式也在不斷調整，鼓勵製造商更早投資於臨床研究，以證明產品的相對療效和手術效率。這些變化並非孤立存在，而是協同作用，共同重塑了採購決策、醫院人員編制模式以及參與企業企業的競爭策略。

深入檢驗2025年貿易政策變化如何重塑醫療設備價值鏈的籌資策略與營運韌性。

2025年關稅和貿易政策調整的實施對醫療設備供應鏈、製造地選擇以及與機器人輸尿管鏡相關的籌資策略產生了連鎖反應。關鍵零件（例如精密塑膠、一次性內視鏡專用特種聚合物和電子機械子系統）的關稅帶來的成本壓力，促使採購部門重新評估供應商集中度，並探索替代來源以維持價格穩定和供應連續性。因此，一些製造商調整了其海外契約製造和區域分散式生產，以降低進口關稅和運輸中斷帶來的風險。

這些變化促使企業更加關注總落地成本而非僅僅是單位成本，從而最佳化庫存管理實踐，重新評估滅菌和分銷模式，並探索關鍵耗材的近岸外包機會。對於依賴專有光學元件、操作模組或無菌一次性組件的設備，契約製造製造商組裝組裝和合格的二級供應商，在新貿易限制下維持生產規模。監管路徑和認證時間表影響了採購變更後組件整合的速度，進一步增加了短期調整的複雜性。

臨床醫生和採購主管也感受到了間接影響，例如產品系列的變化、專業儀器前置作業時間的延長以及對服務網路韌性的重新重視。最終，關稅環境強化了供應鏈多元化、策略供應商夥伴關係以及投資於製造靈活性以抵禦貿易和物流波動等長期趨勢。

將產品組合、滅菌方法、技術架構、終端用戶畫像和臨床應用與策略意義連結起來的綜合細分分析

細緻的市場區隔框架揭示了多樣化的產品組合和臨床路徑如何影響商業化策略。按產品類型分類，市場涵蓋軟式和半硬式輸尿管鏡平台。軟式輸尿管鏡進一步細分為可重複使用和一次性使用，半硬式輸尿管鏡也同樣分為可重複使用和一次性使用。每種配置對消毒、資本支出和手術操作便利性的影響各不相同。從可重複使用/一次性使用的角度來看，市場生態系統分為一次性使用和可重複使用兩種路徑。一次性產品進一步細分為生物可吸收和塑膠兩種亞型，而可重複使用的器械則依賴環氧乙烷或蒸氣滅菌等消毒方法，這些方法會帶來不同的操作和監管要求。

從技術角度出發的細分揭示了兩種主要架構：主動式機器人和半主動式機器人。主動式機器人系統通常由電動和氣動驅動系統驅動，這些系統決定了動態特性、系統尺寸和維護方案。而半主動式機器人則強調自主功能和手動輔助配置，在自動化和臨床醫師控制之間取得平衡。按最終用戶分類的細分揭示了門診手術中心、醫院和研究機構在採購和使用模式上的差異。門診手術中心分為醫院附屬中心和獨立中心，醫院分為私立醫院和公立醫院，研究機構分為學術型和商業型，它們在採用新型機器人平台方面有著不同的獎勵機制。最後，基於應用領域的細分透過分析診斷、取石和治療應用案例，闡明了臨床專業化方向。診斷流程包括切片檢查和影像學檢查，取石主要採用雷射碎石和機械取石技術，治療性介入包括支架置入術和腫瘤消融。

了解這些分割軸的交匯點對於客製化產品設計、臨床檢驗方案、定價策略和分銷模式至關重要。例如，一款針對門診雷射碎石術最佳化的可重複使用軟性內視鏡，與一款用於三級私立醫院複雜消融治療的可重複使用半剛性內視鏡相比，其消毒方法、報銷依據和供應鏈策略都截然不同。

對影響機器人輸尿管鏡全球推廣的促進因素、監管細微差別和供應鏈本地化要求進行全面的區域評估

區域趨勢對機器人輸尿管鏡解決方案的採用時機、採購模式和監管策略有顯著影響。美洲地區對技術先進的平台需求旺盛，這主要得益於其強大的私立醫院網路、完善的門診手術中心體係以及對手術效率和感染控制通訊協定的高度重視。這些市場因素推動了對一次性耗材和整合機器人系統的投資，這些產品有望實現可預測的周轉率並減少再處理負擔，同時也有助於推動醫保報銷談判所需的臨床研究。

歐洲、中東和非洲地區的情況錯綜複雜，各國不同的報銷體系、集中採購計畫以及醫院所有權的多樣性都影響著醫療用品的採用模式。醫療體系集中的國家往往更注重長期成本效益，傾向選擇可重複使用的醫療平台，前提是消毒和生命週期管理能夠最佳化。而中東地區由於醫院容量有限，可能更傾向於使用一次性產品，以減輕再處理負擔並降低交叉感染風險。

亞太地區的特點是基礎設施快速發展、中產階級患者群體不斷壯大，以及製造業和創新日益在地化。該地區的醫療技術應用路徑正在多元化：大型三級醫療機構率先採用先進的機器人手術器械及相關培訓項目，而門診和私立醫院則對經濟實惠的一次性替代方案需求不斷成長。在所有地區，監管協調、本地臨床證據的累積以及供應鏈本地化將是決定機器人輸尿管鏡技術如何在特定醫療體系中推廣應用的關鍵因素。

對生態系統參與者的策略聯盟和能力投資進行分析概述，這些聯盟和投資決定了競爭優勢和商業化成功。

機器人輸尿管鏡領域的組織行為呈現出多元化的特徵，既有成熟的醫療設備原始設備製造商 (OEM)，也有新興的機器人技術專家和契約製造合作夥伴，共同塑造著充滿活力的競爭格局。成熟的設備製造商正利用產品系列。他們關注的重點是與現有影像和雷射系統的兼容性，以及滿足醫院的採購標準。同時，新興企業的、專注於特定領域的機器人公司正在推出差異化的驅動機制、模組化控制平台和一次性設計，挑戰人們對系統複雜性和成本結構的傳統認知。

契約製造製造商和特殊塑膠供應商在批量生產一次性產品方面發揮著至關重要的作用，同時確保產品品質和無菌性。他們與臨床團隊緊密合作，不斷改進人體工學、公差控制和材料選擇，使其能夠承受滅菌或滿足生物可吸收性要求。與臨床研究中心和商業機構建立策略聯盟，能夠加速臨床證據的生成，這對於獲得有利的採購決策以及順利透過優先考慮患者獲益的法規核准流程至關重要。

此外，眾多相關人員正推行垂直整合策略，掌控從光學模組生產到滅菌網路等關鍵價值鏈環節，進而增強自身應對貿易政策變化和供應鏈中斷的能力。智慧財產權策略、上市後監管能力以及能降低整體擁有成本的服務模式，都是企業積極建構的差異化優勢，旨在贏得不同醫療機構的青睞。

為領導者提供切實可行的、優先考慮的策略行動，以加速商業化進程、緩解供應中斷並加強臨床應用途徑。

產業領導者應採取積極主動、多管齊下的策略，使產品策略與營運實際情況和不斷變化的報銷預期相契合。優先考慮模組化系統結構，實現工作模組和光學元件的互換，從而加快產品迭代速度，並為客戶提供清晰的升級路徑。同時，設計一次性醫療器材時，應採用針對無菌製程最佳化的材料，或在臨床適用的情況下使用生物可吸收材料，以減少臨床操作的阻力，並符合機構的感染控制優先事項。

投資於關鍵零件的本地生產或合格的二級供應商，以降低貿易政策和物流風險；並制定靈活的前置作業時間承諾和緊急時應對計畫，以建立商業協議。加強臨床證據項目，重點關注真實世界的比較療效、工作流程效率和以患者為中心的結果，因為支付方和採購決策除了安全性和有效性結果外，越來越需要可靠的營運數據。與高運轉率的臨床中心建立深度合作關係，以扶持早期採用者，並產生經同儕審查的臨床促進者，從而支持廣泛應用。

最後，採用能夠減輕醫院員工新進員工入職負擔的服務和培訓模式，例如整合模擬課程和遠端監控功能。透過進行透明的上市後監測和基於臨床醫生回饋的持續改進，在產品生命週期內維護信任並展現持續的價值創造。

混合方法研究途徑、同儕檢驗和資料三角測量技術均以透明的方式進行解釋，以確保研究結果的嚴謹性和可操作性。

本分析的調查方法結合了定性和定量方法，以確保獲得可靠且可操作的見解。主要研究包括對門診手術中心、公立和私立醫院、學術和商業研究機構的臨床醫生進行結構化訪談，以及與採購經理、消毒專家和醫療設備技術人員進行對話，以了解操作流程和技術要求。這些訪談探討了他們對設備性能、消毒流程、採購標準和實施障礙的看法，提供了豐富的背景資訊，並以此為基礎進行了市場細分和區域分析。

我們的二次研究包括對監管指南、臨床文獻、專利申請和上市公司資訊披露的系統性回顧，檢驗技術趨勢和競爭地位，而不依賴專有的市場預測。我們採用資料三角測量法來協調相互矛盾的訊息，並檢驗來自多個資訊來源的假設。情境分析評估了貿易政策變化和供應鏈中斷對各類產品類型籌資策略和上市時間的影響。

最後，為確保調查方法的嚴謹性和實用性，我們透過同儕審查和由獨立臨床專家組成的諮詢委員會進行了檢驗。其局限性包括不同醫療系統採購模式的差異以及監管路徑的不斷演變，這些都需要持續監測和迭代更新以保持其準確性。

總之，我們重點闡述了臨床證據供應鏈韌性和商業準備度策略交會點的關鍵成功因素。

機器人輸尿管鏡檢查正從一項前景廣闊的臨床輔助手段過渡到一項成熟的技術，這需要精細的商業化策略和穩健的營運模式。一次性器材與可重複使用器材之間的互動、主動式和半主動式機器人架構的興起，以及在地化生產的戰略意義，都為製造商、醫療系統和臨床創新者帶來了挑戰和機會。成功的關鍵在於：使產品設計符合消毒要求；提供能夠引起支付方和採購團隊共鳴的有力臨床證據；以及建立一條足夠靈活的供應鏈，以應對貿易和物流方面的壓力。

臨床醫生將受益於更符合人體工學的設計、更高的可重複性和更精準的操作，而醫院和門診醫療機構則可透過將該技術與周全的培訓和服務模式相結合，實現營運效率的提升。對於產業相關人員而言，未來的發展方向在於將技術差異化與對無菌工作流程、監管合規性和加速臨床檢驗的夥伴關係模式的實際關注相結合。透過聚焦這些優先事項，相關人員將能夠更好地應對短期挑戰，並最終實現機器人輸尿管鏡檢查的長期臨床和商業性價值潛力。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 人工智慧導航系統正日益整合到內視鏡系統中，以最佳化內視鏡導航並縮短手術時間。
  • 開發一次性機器人輸尿管鏡（內建數位成像感測器，提高了無菌性和影像品質）
  • 泌尿系統設備製造商與軟體開發商建立策略夥伴關係，加速智慧手術工作流程解決方案的發展。
  • 門診手術中心對微創機器人輸尿管鏡系統的需求增加（以縮短病患恢復時間）
  • 擴展遠端機器人輸尿管鏡平台，可在全球醫療機構提供遠距手術輔助和培訓。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的機器人輸尿管鏡市場

  • 軟式輸尿管鏡
    • 可重複使用的
    • 一次使用
  • 半硬式輸尿管鏡
    • 可重複使用的
    • 一次使用

9. 機器人輸尿管鏡市場：可重複使用型與一次性型

  • 一次性
    • 生物可吸收
    • 塑膠
  • 可重複使用的
    • 環氧乙烷
    • 蒸氣滅菌

第10章 依技術分類的機器人輸尿管鏡市場

  • 主動機器人
    • 電動驅動系統
    • 氣動驅動
  • 半主動機器人
    • 自主
    • 手動輔助

第11章 以最終用戶分類的機器人輸尿管鏡市場

  • 門診手術中心
    • 醫院附屬機構
    • 獨立設施
  • 醫院
    • 私立醫院
    • 公立醫院
  • 研究所
    • 學術機構
    • 商業的

第12章 按應用分類的機器人輸尿管鏡市場

  • 診斷
    • 切片檢查
    • 影像診斷
  • 移除石頭
    • 雷射碎石術
    • 機械萃取
  • 治療
    • 支架置入
    • 腫瘤消融

第13章 區域機器人輸尿管鏡市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 機器人輸尿管鏡市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國機器人輸尿管鏡市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Intuitive Surgical, Inc.
    • Auris Health, Inc.
    • XACT Robotics, Inc.
    • Anzu Medical, Inc.
    • ELMED SA
Product Code: MRR-521BAA36ECC3

The Robotic Ureteroscopy Market is projected to grow by USD 2,059.05 million at a CAGR of 16.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 598.93 million
Estimated Year [2025] USD 697.20 million
Forecast Year [2032] USD 2,059.05 million
CAGR (%) 16.69%

Comprehensive contextual overview of robotic ureteroscopy technologies clinical drivers and operational considerations shaping near-term adoption

Robotic ureteroscopy is redefining endourology by combining precision instrumentation, advanced optics, and evolving robotic actuation to improve procedural ergonomics and clinical outcomes. As clinicians seek solutions that reduce fatigue, enhance dexterity within tortuous anatomies, and enable more consistent control of laser-based lithotripsy and therapeutic interventions, robotic systems are emerging as an important adjunct to traditional endoscopes and manual techniques. Beyond clinical performance, the technology narrative is increasingly shaped by operational considerations including sterilization logistics, single-use device workflows, and procurement strategies that affect hospital throughput and per-procedure cost drivers.

This section sets the stage for the analysis by describing the core technology categories, device configurations, and clinical use cases that define current adoption patterns. It emphasizes the interplay between flexible and semi-rigid scopes, the growing interest in single-use versus reusable options to mitigate cross-contamination risk, and how different sterilization pathways influence hospital operations. It also introduces the dichotomy between active and semi-active robotic paradigms, which determine system complexity, control fidelity, and integration with existing urology suites.

With an eye toward stakeholders across operating rooms, ambulatory surgical centers, and research institutions, the introduction frames the key clinical and commercial questions that follow: which technology pathways align best with specific clinical applications such as diagnostic biopsy, stone extraction, and therapeutic ablation; how regulatory and procurement landscapes shape adoption; and where value creation is concentrated for device manufacturers, service providers, and clinical leaders.

Strategic synthesis of technological clinical and commercial inflection points that are reshaping adoption dynamics in robotic ureteroscopy

The robotic ureteroscopy landscape is undergoing multiple transformative shifts that are simultaneously technical, clinical, and commercial. On the technical front, the transition from purely manual endoscopic manipulation toward systems with electric or pneumatic actuation, refined haptic interfaces, and semi-autonomous features is accelerating procedural precision while reducing operator variability. These advances are complemented by improvements in optics, laser delivery, and energy modulation, which expand the therapeutic envelope for stone removal and tumor ablation.

Clinically, care delivery is moving toward minimally invasive workflows that prioritize throughput, infection control, and consistent outcomes. Single-use devices are gaining traction in environments that need to limit cross-contamination and streamline turnover, while reusable platforms continue to evolve around robust sterilization protocols and lifecycle management. Commercially, the ecosystem is fragmenting into established device OEMs, specialist robotics firms, and contract manufacturing partners that can scale production of both disposables and complex mechatronic assemblies. This shift fuels new collaboration models, strategic partnerships, and targeted investments in clinical evidence generation.

Regulatory frameworks and payer pathways are adapting as well, prompting manufacturers to invest earlier in clinical studies that demonstrate comparative effectiveness and procedural efficiency. Taken together, these shifts are not isolated; they compound to reshape procurement decisions, hospital staffing models, and the competitive calculus for entrants and incumbents alike.

In-depth examination of how 2025 trade policy shifts have reshaped supply chains sourcing strategies and operational resilience across the device value chain

The introduction of tariffs and trade policy adjustments in 2025 has had a cascading influence across the device supply chain, manufacturing footprint decisions, and sourcing strategies relevant to robotic ureteroscopy. Tariff-induced cost pressures on key components, including precision plastics, specialty polymers used in single-use scopes, and electromechanical subsystems, prompted procurement teams to reassess vendor concentration and pursue alternative sourcing to preserve price stability and supply continuity. In response, several manufacturers reconsidered the balance between offshore contract manufacturing and regionalized production to mitigate exposure to import levies and transportation disruptions.

These shifts intensified focus on total landed cost rather than unit price alone, motivating organizations to optimize inventory practices, reevaluate sterilization and distribution models, and explore nearshoring opportunities for critical consumables. For devices that rely on proprietary optics, actuation modules, or sterile disposable elements, contract manufacturers adapted by localizing assembly or qualifying secondary suppliers to maintain throughput under new trade constraints. Regulatory pathways and certification timelines affected the speed at which re-sourced components could be integrated, further complicating short-term adjustments.

Clinicians and procurement leaders experienced indirect effects through altered product portfolios, occasional lead-time elongation for specialized instruments, and renewed attention to the resilience of service networks. Ultimately, the tariff environment reinforced a longer-term trend toward supply chain diversification, strategic supplier partnerships, and investment in manufacturing flexibility to withstand episodic trade and logistics volatility.

Comprehensive segmentation analysis linking product configurations sterilization approaches technology architectures end user profiles and clinical applications to strategic implications

A nuanced segmentation framework reveals the multiplicity of product configurations and clinical pathways influencing commercialization strategies. Based on product type the market encompasses both Flexible Ureteroscope and Semi Rigid Ureteroscope platforms; the Flexible Ureteroscope category further differentiates into Multi Use and Single Use designs while the Semi Rigid Ureteroscope similarly splits into Multi Use and Single Use variants, each configuration carrying distinct implications for sterilization, capital expenditure, and procedural ergonomics. When viewed through the lens of reusable versus disposable considerations the ecosystem divides into Disposable and Reusable pathways; Disposable options are further categorized into Bioabsorbable and Plastic subtypes whereas Reusable instruments rely on sterilization methodologies such as Ethylene Oxide and Steam Sterilization which impose different operational and regulatory requirements.

Technology-focused segmentation uncovers two principal architectures: Active Robotics and Semi Active Robotics. Active Robotics systems are commonly realized through Electric Actuation and Pneumatic Actuation approaches that define force profiles, system footprint, and maintenance regimes, while Semi Active Robotics emphasizes Autonomous features and Manual Assist configurations that balance automation with clinician control. End user segmentation highlights distinct procurement and utilization patterns across Ambulatory Surgical Center, Hospital, and Research Institute settings; Ambulatory Surgical Centers bifurcate into Hospital Affiliated and Standalone models, Hospitals split into Private Hospital and Public Hospital categories, and Research Institutes separate into Academic and Commercial types, each with unique incentive structures for adopting novel robotic platforms. Finally, application-based segmentation clarifies clinical specialization by parsing Diagnostic, Stone Removal, and Therapeutic use cases; Diagnostic workflows include Biopsy and Imaging subsets, Stone Removal is driven by Laser Lithotripsy and Mechanical Extraction techniques, and Therapeutic interventions encompass Stent Placement and Tumor Ablation procedures.

Understanding how these segmentation axes intersect is essential for tailoring product design, clinical validation programs, pricing strategies, and distribution models. For example, a single-use flexible scope optimized for laser lithotripsy in ambulatory settings will require a different sterilization narrative, reimbursement evidence, and supply chain approach compared with a reusable semi-rigid system designed for complex therapeutic ablation in a tertiary private hospital.

Holistic regional appraisal of adoption catalysts regulatory nuances and supply chain localization imperatives shaping global deployment of robotic ureteroscopy

Regional dynamics exert a powerful influence on adoption timing, procurement modality, and regulatory strategy for robotic ureteroscopy solutions. The Americas demonstrates a pronounced appetite for technologically advanced platforms, driven by robust private hospital networks, an extensive ambulatory surgical center ecosystem, and an emphasis on procedural efficiency and infection control protocols. These market forces favor investments in single-use disposables and integrated robotic systems that promise predictable turnover and reduced reprocessing burden, while also supporting clinical studies needed for reimbursement conversations.

Europe Middle East & Africa presents a complex mosaic where national reimbursement frameworks, centralized procurement programs, and varied hospital ownership models shape adoption patterns. Countries with centralized health systems often prioritize long-term cost-effectiveness, which supports reusable platforms if sterilization and lifecycle management can be optimized. Meanwhile, regions grappling with constrained hospital capacity may favor disposables to alleviate reprocessing strain and limit cross-infection risk.

Asia-Pacific is characterized by rapid infrastructure development, a growing middle-class patient base, and a strong push to localize manufacturing and innovation. This region exhibits mixed adoption pathways: major tertiary centers drive early uptake of advanced robotic instruments and associated training programs, while ambulatory and private hospital segments increasingly demand cost-effective single-use alternatives. Across all regions, regulatory harmonization efforts, local clinical evidence generation, and supply chain localization are pivotal determinants of how and when robotic ureteroscopy technologies scale within specific healthcare systems.

Analytical overview of ecosystem participants strategic partnerships and capability investments that determine competitive advantage and commercialization success

Organizational behavior in the robotic ureteroscopy field is defined by a blend of incumbent medical device OEMs, emerging robotics specialists, and contract manufacturing partners that together construct a dynamic competitive landscape. Established device manufacturers are leveraging their clinical relationships and distribution networks to broaden their portfolios through internal development or strategic partnerships, focusing on compatibility with existing imaging and laser systems and on meeting hospital procurement criteria. At the same time, start-ups and niche robotics firms are introducing differentiated actuation schemes, modular control platforms, and single-use disposable designs that challenge legacy assumptions about system complexity and cost structures.

Contract manufacturers and specialized plastics suppliers play a critical role in scaling single-use offerings while maintaining consistent quality and sterility. They collaborate closely with clinical teams to refine ergonomics, tolerances, and material selections that withstand sterilization or fulfill bioabsorbable specifications. Strategic alliances between clinical research centers and commercial entities accelerate clinical evidence generation, which is increasingly necessary for favorable procurement decisions and for navigating regulatory pathways that prioritize demonstrable patient benefit.

Additionally, several actors are pursuing vertical integration strategies to control key value chain elements, from optical module production to sterilization networks, enhancing resilience to trade policy shifts and supply disruptions. Intellectual property strategies, post-market surveillance capabilities, and service models that reduce total cost of ownership are all differentiators that companies are actively cultivating to win adoption in diverse healthcare settings.

Practical and prioritized strategic actions for leaders to accelerate commercialization mitigate supply disruptions and strengthen clinical adoption pathways

Industry leaders should adopt a proactive, multi-dimensional playbook that aligns product strategy with operational realities and evolving reimbursement expectations. Prioritize modular system architectures that allow for interchangeable actuation modules and optics, enabling faster product iterations and clearer upgrade paths for customers. Simultaneously, design single-use devices with materials optimized for sterilization pathways or bioabsorbable use where clinically appropriate, thereby reducing clinical friction and aligning with institutional infection control priorities.

Invest in localized manufacturing or qualified secondary suppliers for critical components to mitigate trade policy and logistics risks, and structure commercial agreements to include flexible lead-time commitments and contingency plans. Bolster clinical evidence programs that emphasize real-world comparative effectiveness, workflow efficiency, and patient-centered outcomes, since payer and procurement decisions increasingly require robust operational data in addition to safety and efficacy results. Cultivate deep collaborations with high-volume clinical centers to foster early adoption champions and generate peer-reviewed clinical narratives that support broader acceptance.

Finally, adopt service and training models that reduce the adoption burden on hospital staff, such as integrated simulation curricula and remote proctoring capabilities. Commit to transparent post-market surveillance and iterative improvements informed by clinician feedback to maintain trust and demonstrate continuous value creation over the product lifecycle.

Transparent explanation of the mixed methods research approach expert validation and data triangulation techniques ensuring rigorous and actionable insights

The research methodology underpinning this analysis combines qualitative and quantitative approaches to ensure robust and actionable findings. Primary research consisted of structured interviews with clinicians across ambulatory surgical centers, private and public hospitals, and academic and commercial research institutes, along with conversations with procurement leaders, sterilization specialists, and device engineers to capture operational realities and technology requirements. These interviews explored device performance, sterilization workflows, purchasing criteria, and perceived barriers to adoption, providing rich contextual insights that informed segmentation and regional analysis.

Secondary research included a systematic review of regulatory guidelines, clinical literature, patent filings, and public company disclosures to validate technology trends and competitive positioning without relying on proprietary market estimates. Data triangulation methods were used to reconcile conflicting inputs and to test assumptions across multiple sources. Scenario analysis evaluated the implications of trade policy shifts and supply chain disruptions on sourcing strategies and time-to-market for various product categories.

Finally, findings were peer-reviewed by independent clinical experts and validated through advisory panels to ensure methodological rigor and practical relevance. Limitations include variability in procurement models across health systems and the evolving nature of regulatory pathways, which require ongoing monitoring and iterative updates to maintain contemporary accuracy.

Concluding synthesis articulating the critical success factors and the strategic intersection of clinical evidence supply chain resilience and commercialization readiness

Robotic ureteroscopy is transitioning from a promising clinical adjunct to a mature technology category that demands nuanced commercialization strategies and resilient operational models. The interplay between single-use and reusable device narratives, the rise of active and semi-active robotic architectures, and the strategic implications of localized manufacturing create both challenges and opportunities for manufacturers, health systems, and clinical innovators. Success will hinge on aligning product design with sterilization imperatives, delivering compelling clinical evidence that resonates with payers and procurement teams, and building supply chains that can flex in response to trade and logistics stresses.

Clinicians stand to benefit from improved ergonomics, reproducibility, and procedural precision, while hospitals and ambulatory providers can realize operational gains if technologies are integrated with thoughtful training and service models. For industry players, the pathway forward involves combining technological differentiation with practical attention to sterilization workflows, regulatory readiness, and partnership models that accelerate clinical validation. By focusing on these priorities, stakeholders can navigate near-term disruptions and position themselves to realize the long-term clinical and commercial potential of robotic ureteroscopy.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing integration of AI guidance systems to optimize endoscopic navigation and reduce procedure times
  • 5.2. Development of single-use robotic ureteroscopes with embedded digital imaging sensors for improved sterility and image quality
  • 5.3. Strategic partnerships between urology device firms and software developers to accelerate smart operative workflow solutions
  • 5.4. Growing demand for minimally invasive robotic ureteroscopy systems in ambulatory surgical centers to lower patient recovery times
  • 5.5. Expansion of teleoperated robotic ureteroscopy platforms enabling remote procedural support and training across global healthcare facilities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic Ureteroscopy Market, by Product Type

  • 8.1. Flexible Ureteroscope
    • 8.1.1. Multi Use
    • 8.1.2. Single Use
  • 8.2. Semi Rigid Ureteroscope
    • 8.2.1. Multi Use
    • 8.2.2. Single Use

9. Robotic Ureteroscopy Market, by Reusable Vs Disposable

  • 9.1. Disposable
    • 9.1.1. Bioabsorbable
    • 9.1.2. Plastic
  • 9.2. Reusable
    • 9.2.1. Ethylene Oxide
    • 9.2.2. Steam Sterilization

10. Robotic Ureteroscopy Market, by Technology

  • 10.1. Active Robotics
    • 10.1.1. Electric Actuation
    • 10.1.2. Pneumatic Actuation
  • 10.2. Semi Active Robotics
    • 10.2.1. Autonomous
    • 10.2.2. Manual Assist

11. Robotic Ureteroscopy Market, by End User

  • 11.1. Ambulatory Surgical Center
    • 11.1.1. Hospital Affiliated
    • 11.1.2. Standalone
  • 11.2. Hospital
    • 11.2.1. Private Hospital
    • 11.2.2. Public Hospital
  • 11.3. Research Institute
    • 11.3.1. Academic
    • 11.3.2. Commercial

12. Robotic Ureteroscopy Market, by Application

  • 12.1. Diagnostic
    • 12.1.1. Biopsy
    • 12.1.2. Imaging
  • 12.2. Stone Removal
    • 12.2.1. Laser Lithotripsy
    • 12.2.2. Mechanical Extraction
  • 12.3. Therapeutic
    • 12.3.1. Stent Placement
    • 12.3.2. Tumor Ablation

13. Robotic Ureteroscopy Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Robotic Ureteroscopy Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Robotic Ureteroscopy Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Intuitive Surgical, Inc.
    • 16.3.2. Auris Health, Inc.
    • 16.3.3. XACT Robotics, Inc.
    • 16.3.4. Anzu Medical, Inc.
    • 16.3.5. ELMED S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE VS DISPOSABLE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE VS DISPOSABLE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ROBOTIC URETEROSCOPY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ROBOTIC URETEROSCOPY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ROBOTIC URETEROSCOPY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ROBOTIC URETEROSCOPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MULTI USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE VS DISPOSABLE, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE VS DISPOSABLE, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STEAM STERILIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STEAM STERILIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STEAM STERILIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STEAM STERILIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ELECTRIC ACTUATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ELECTRIC ACTUATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ELECTRIC ACTUATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ELECTRIC ACTUATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ELECTRIC ACTUATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ELECTRIC ACTUATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PNEUMATIC ACTUATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PNEUMATIC ACTUATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PNEUMATIC ACTUATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PNEUMATIC ACTUATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PNEUMATIC ACTUATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PNEUMATIC ACTUATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AUTONOMOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AUTONOMOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AUTONOMOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AUTONOMOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AUTONOMOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AUTONOMOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MANUAL ASSIST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MANUAL ASSIST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MANUAL ASSIST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MANUAL ASSIST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MANUAL ASSIST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MANUAL ASSIST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STANDALONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STANDALONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STANDALONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STANDALONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STANDALONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STANDALONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACADEMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACADEMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY COMMERCIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MECHANICAL EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MECHANICAL EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MECHANICAL EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MECHANICAL EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MECHANICAL EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY MECHANICAL EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STENT PLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STENT PLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STENT PLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STENT PLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY STENT PLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TUMOR ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TUMOR ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY TUMOR ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ROBOTIC URETEROSCOPY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE VS DISPOSABLE, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE VS DISPOSABLE, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS ROBOTIC URETEROSCOPY MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY FLEXIBLE URETEROSCOPE, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI RIGID URETEROSCOPE, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE VS DISPOSABLE, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE VS DISPOSABLE, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY DISPOSABLE, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY ACTIVE ROBOTICS, 2025-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, 2018-2024 (USD MILLION)
  • TABLE 312. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY SEMI ACTIVE ROBOTICS, 2025-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 314. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2018-2024 (USD MILLION)
  • TABLE 316. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, 2025-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
  • TABLE 318. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY HOSPITAL, 2025-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, 2018-2024 (USD MILLION)
  • TABLE 320. NORTH AMERICA ROBOTIC URETEROSCOPY MARKET SIZE, BY RESEARCH INSTITUTE, 202